This review argues that the field is advancing from circumventing to reversing and ultimately leveraging limitations to activate systemic anti-tumor immunity. This perspective offers a powerful new lens to view current and future developments.
Aili et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: